3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold

References

• Abbasi, M., Ramezani, F., Elyasi, M., Sadeghi-Aliabadi, H., & Amanlou, M. (2015). A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold. DARU Journal of Pharmaceutical Sciences, 23, 1–10.
   Google Scholar
• Abbasi, M., Sadeghi-Aliabadi, H., Hassanzadeh, F., & Amanlou, M. (2015). Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening. Journal of Molecular Graphics and Modelling, 61, 186–195.10.1016/j.jmgm.2015.08.001
   PubMed Web of Science ®Google Scholar
• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25.10.1016/j.softx.2015.06.001
   Google Scholar
• Athar, M., Lone, M. Y., Khedkar, V. M., & Jha, P. C. (2016). Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design. Journal of Biomolecular Structure and Dynamics, 34, 1282–1297.10.1080/07391102.2015.1077343
   PubMed Web of Science ®Google Scholar
• Azizian, H., Bahrami, H., Pasalar, P., & Amanlou, M. (2010). Molecular modeling of Helicobacter pylori arginase and the inhibitor coordination interactions. Journal of Molecular Graphics and Modelling, 28, 626–635.10.1016/j.jmgm.2009.12.007
   PubMed Web of Science ®Google Scholar
• Bargiotti, A., Musso, L., Dallavalle, S., Merlini, L., Gallo, G., Ciacci, A., … Vesci, L. (2012). Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors. European Journal of Medicinal Chemistry, 53, 64–75.10.1016/j.ejmech.2012.03.036
   PubMed Web of Science ®Google Scholar
• Baruchello, R., Simoni, D., Grisolia, G., Barbato, G., Marchetti, P., Rondanin, R., … Alloatti, D. (2011). Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90. Journal of Medicinal Chemistry, 54, 8592–8604.10.1021/jm201155e
   PubMed Web of Science ®Google Scholar
• Baruchello, R., Simoni, D., Marchetti, P., Rondanin, R., Mangiola, S., Costantini, C., … Carollo, V. (2014). 4, 5, 6, 7-Tetrahydro-isoxazolo-[4, 5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors. European Journal of Medicinal Chemistry, 76, 53–60.10.1016/j.ejmech.2014.01.056
   PubMed Web of Science ®Google Scholar
• Bringmann, G., & Rummey, C. (2003). 3D QSAR investigations on antimalarial naphthylisoquinoline alkaloids by comparative molecular similarity indices analysis (CoMSIA), based on different alignment approaches. Journal of Chemical Information and Computer Sciences, 43, 304–316.10.1021/ci025570s
   PubMedGoogle Scholar
• Bruncko, M., Tahir, S. K., Song, X., Chen, J., Ding, H., Huth, J. R., … Park, C. H. (2010). N-Aryl-benzimidazolones as novel small molecule HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters, 20, 7503–7506.10.1016/j.bmcl.2010.10.010
   PubMed Web of Science ®Google Scholar
• Chauhan, J. S., Dhanda, S. K., Singla, D., Agarwal, S. M., Raghava, G. P., & Consortium, O. S. D. D. (2014). QSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFR. PLoS ONE, 9, e101079.10.1371/journal.pone.0101079
   PubMed Web of Science ®Google Scholar
• Chen, D., Shen, A., Li, J., Shi, F., Chen, W., Ren, J., … Yang, X. (2014). Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors. European Journal of Medicinal Chemistry, 87, 765–781.10.1016/j.ejmech.2014.09.065
   PubMed Web of Science ®Google Scholar
• Cosconati, S., Forli, S., Perryman, A. L., Harris, R., Goodsell, D. S., & Olson, A. J. (2010). Virtual screening with AutoDock: Theory and practice. Expert Opinion on Drug Discovery, 5, 597–607.10.1517/17460441.2010.484460
   PubMed Web of Science ®Google Scholar
• Cramer, R. D., Bunce, J. D., Patterson, D. E., & Frank, I. E. (1988). Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quantitative Structure-Activity Relationships, 7, 18–25.10.1002/qsar.v7:1
   Google Scholar
• Frisch, M. (1998). Gaussian98, revision A. 7. Pittsburgh, PA: Gaussian, Inc.
   Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., & Scuseria, G. E. (2004). Gaussian03, revision C. 01. Wallingford, CT: Gaussian, Inc.
   Google Scholar
• Gadaleta, D., Mangiatordi, G. F., Catto, M., Carotti, A., & Nicolotti, O. (2016). Applicability domain for QSAR models. International Journal of Quantitative Structure-Property Relationships, 1, 45–63.10.4018/IJQSPR
   Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38.10.1016/0263-7855(96)00018-5
   PubMed Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37, 4130–4146.10.1021/jm00050a010
   PubMed Web of Science ®Google Scholar
• Ma, S., Zeng, G., Fang, D., Wang, J., Wu, W., Xie, W., … Zheng, K. (2015). Studies of N 9-arenthenyl purines as novel DFG-in and DFG-out dual Src/Abl inhibitors using 3D-QSAR, docking and molecular dynamics simulations. Molecular BioSystems, 11, 394–406.10.1039/C4MB00350K
   PubMed Web of Science ®Google Scholar
• Makarewicz, T., & Kaźmierkiewicz, R. (2013). Molecular dynamics simulation by GROMACS using GUI plugin for PyMOL. Journal of Chemical Information and Modeling, 53, 1229–1234.10.1021/ci400071x
   PubMed Web of Science ®Google Scholar
• McLaughlin, S. H., Sobott, F., Yao, Z.-P., Zhang, W., Nielsen, P. R., Grossmann, J. G., … Jackson, S. E. (2006). The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. Journal of Molecular Biology, 356, 746–758.10.1016/j.jmb.2005.11.085
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662.10.1002/(ISSN)1096-987X
   Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30, 2785–2791.10.1002/jcc.v30:16
   PubMed Web of Science ®Google Scholar
• Musso, L., Cincinelli, R., Giannini, G., Manetti, F., & Dallavalle, S. (2015). Synthesis of 5, 6‐dihydro‐4H‐benzo [d] isoxazol‐7‐one and 5, 6‐dihydro‐4H‐isoxazolo [5, 4‐c] pyridin‐7‐one Derivatives as Potential Hsp90 Inhibitors. Chemical Biology & Drug Design, 86, 1030–1035.10.1111/cbdd.12570
   PubMed Web of Science ®Google Scholar
• Ouyang, L., He, G., Huang, W., Song, X., Wu, F., & Xiang, M. (2012). Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors. International Journal of Molecular Sciences, 13, 5348–5363.10.3390/ijms13055348
   PubMed Web of Science ®Google Scholar
• Porter, J. R., Fritz, C. C., & Depew, K. M. (2010). Discovery and development of Hsp90 inhibitors: A promising pathway for cancer therapy. Current Opinion in Chemical Biology, 14, 412–420.10.1016/j.cbpa.2010.03.019
   PubMed Web of Science ®Google Scholar
• Pourbasheer, E., Bazl, R., & Amanlou, M. (2014). Molecular docking and 3D-QSAR studies on the MAPKAP-K2 inhibitors. Medicinal Chemistry Research, 23, 2252–2263.10.1007/s00044-013-0820-0
   Web of Science ®Google Scholar
• PyMOL. (2010). The PyMOL molecular graphics system: Version. San Carlos, CA: DeLano Scientific.
   Google Scholar
• Roy, K., Kar, S., & Ambure, P. (2015). On a simple approach for determining applicability domain of QSAR models. Chemometrics and Intelligent Laboratory Systems, 145, 22–29.10.1016/j.chemolab.2015.04.013
   Web of Science ®Google Scholar
• Roy, K., Kar, S., & Das, R. N. (2015). Understanding the basics of QSAR for applications in pharmaceutical sciences and risk assessment. New York: Academic Press.
   Google Scholar
• Schmid, N., Eichenberger, A. P., Choutko, A., Riniker, S., Winger, M., Mark, A. E., & van Gunsteren, W. F. (2011). Definition and testing of the GROMOS force-field versions 54A7 and 54B7. European Biophysics Journal, 40, 843–856.10.1007/s00249-011-0700-9
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D: Biological Crystallography, 60, 1355–1363.10.1107/S0907444904011679
   PubMed Web of Science ®Google Scholar
• Sharma, S. V., Agatsuma, T., & Nakano, H. (1998). Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene, 16, 2639–2645.10.1038/sj.onc.1201790
   PubMed Web of Science ®Google Scholar
• Sharp, S. Y., Prodromou, C., Boxall, K., Powers, M. V., Holmes, J. L., Box, G., … James, K. (2007). Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues. Molecular Cancer Therapeutics, 6, 1198–1211.10.1158/1535-7163.MCT-07-0149
   PubMed Web of Science ®Google Scholar
• Søndergaard, C. R., Olsson, M. H., Rostkowski, M., & Jensen, J. H. (2011). Improved treatment of ligands and coupling effects in empirical calculation and rationalization of p K a values. Journal of Chemical Theory and Computation, 7, 2284–2295.10.1021/ct200133y
   PubMed Web of Science ®Google Scholar
• Sun, J., Lin, C., Qin, X., Dong, X., Tu, Z., Tang, F., … Zhang, J. (2015). Synthesis and biological evaluation of 3, 5-disubstituted-4-alkynylisoxozales as a novel class of HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters, 25, 3129–3134.10.1016/j.bmcl.2015.06.009
   PubMed Web of Science ®Google Scholar
• Tripuraneni, N. S., & Azam, M. A. (2016). A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors. Journal of Biomolecular Structure and Dynamics, 34, 2481–2492.10.1080/07391102.2015.1119732
   PubMed Web of Science ®Google Scholar
• Wandinger, S. K., Richter, K., & Buchner, J. (2008). The Hsp90 chaperone machinery. Journal of Biological Chemistry, 283, 18473–18477.10.1074/jbc.R800007200
   PubMed Web of Science ®Google Scholar
• Yang, Y., Wang, J., Li, Y., Xiao, W., Wang, Z., Zhang, J., … Yang, L. (2013). Structure determinants of indolin-2-on-3-spirothiazolidinones as MptpB inhibitors: An in silico study. Soft Matter, 9, 11054–11077.10.1039/c3sm51995c
   Web of Science ®Google Scholar
• Zhou, S., Fang, D., Tan, S., Lin, W., Wu, W., & Zheng, K. (2016). Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y12 by 3D-QSAR, docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 1–28.
   Web of Science ®Google Scholar